• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

医疗保险人群中重症 COVID-19 的预测模型:一种用于确定 COVID-19 初种和加强疫苗接种优先级的工具。

A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination.

作者信息

Experton Bettina, Tetteh Hassan A, Lurie Nicole, Walker Peter, Elena Adrien, Hein Christopher S, Schwendiman Blake, Vincent Justin L, Burrow Christopher R

机构信息

Humetrix Inc., Del Mar, CA 90214, USA.

Warfighter Health Mission Team, Department of Defense Joint Artificial Intelligence Center (JAIC), Arlington, VA 22202, USA.

出版信息

Biology (Basel). 2021 Nov 15;10(11):1185. doi: 10.3390/biology10111185.

DOI:10.3390/biology10111185
PMID:34827181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8614832/
Abstract

Recommendations for prioritizing COVID-19 vaccination have focused on the elderly at higher risk for severe disease. Existing models for identifying higher-risk individuals lack the needed integration of socio-demographic and clinical risk factors. Using multivariate logistic regression and random forest modeling, we developed a predictive model of severe COVID-19 using clinical data from Medicare claims for 16 million Medicare beneficiaries and socio-economic data from the CDC Social Vulnerability Index. Predicted individual probabilities of COVID-19 hospitalization were then calculated for population risk stratification and vaccine prioritization and mapping. The leading COVID-19 hospitalization risk factors were non-white ethnicity, end-stage renal disease, advanced age, prior hospitalization, leukemia, morbid obesity, chronic kidney disease, lung cancer, chronic liver disease, pulmonary fibrosis or pulmonary hypertension, and chemotherapy. However, previously reported risk factors such as chronic obstructive pulmonary disease and diabetes conferred modest hospitalization risk. Among all social vulnerability factors, residence in a low-income zip code was the only risk factor independently predicting hospitalization. This multifactor risk model and its population risk dashboard can be used to optimize COVID-19 vaccine allocation in the higher-risk Medicare population.

摘要

优先进行新冠病毒疫苗接种的建议主要集中在患重病风险较高的老年人身上。现有的识别高风险个体的模型缺乏对社会人口统计学和临床风险因素的必要整合。我们使用多变量逻辑回归和随机森林建模,利用来自1600万医疗保险受益人的医疗保险理赔临床数据以及来自疾病控制与预防中心社会脆弱性指数的社会经济数据,开发了一个预测严重新冠病毒疾病的模型。然后计算出新冠病毒住院的个体预测概率,用于人群风险分层、疫苗接种优先级确定和绘制地图。导致新冠病毒住院的主要风险因素包括非白人种族、终末期肾病、高龄、既往住院史、白血病、病态肥胖、慢性肾病、肺癌、慢性肝病、肺纤维化或肺动脉高压以及化疗。然而,之前报道的风险因素如慢性阻塞性肺疾病和糖尿病导致的住院风险相对较小。在所有社会脆弱性因素中,居住在低收入邮政编码地区是唯一能独立预测住院的风险因素。这个多因素风险模型及其人群风险仪表盘可用于优化在风险较高的医疗保险人群中新冠病毒疫苗的分配。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/7a977c5c404a/biology-10-01185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/27c76eb085f0/biology-10-01185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/0fd867ac8eb2/biology-10-01185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/6cd55ba56299/biology-10-01185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/422c8a96d580/biology-10-01185-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/7a977c5c404a/biology-10-01185-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/27c76eb085f0/biology-10-01185-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/0fd867ac8eb2/biology-10-01185-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/6cd55ba56299/biology-10-01185-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/422c8a96d580/biology-10-01185-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8bd9/8614832/7a977c5c404a/biology-10-01185-g005.jpg

相似文献

1
A Predictive Model for Severe COVID-19 in the Medicare Population: A Tool for Prioritizing Primary and Booster COVID-19 Vaccination.医疗保险人群中重症 COVID-19 的预测模型:一种用于确定 COVID-19 初种和加强疫苗接种优先级的工具。
Biology (Basel). 2021 Nov 15;10(11):1185. doi: 10.3390/biology10111185.
2
Association of pre-existing comorbidities with mortality and disease severity among 167,500 individuals with COVID-19 in Canada: A population-based cohort study.在加拿大,167500 例 COVID-19 患者中,先前存在的合并症与死亡率和疾病严重程度的关系:一项基于人群的队列研究。
PLoS One. 2021 Oct 5;16(10):e0258154. doi: 10.1371/journal.pone.0258154. eCollection 2021.
3
Natural History of Coronavirus Disease 2019: Risk Factors for Hospitalizations and Deaths Among >26 Million US Medicare Beneficiaries.2019 年冠状病毒病的自然史:2600 多万美国医疗保险受益人的住院和死亡风险因素。
J Infect Dis. 2021 Mar 29;223(6):945-956. doi: 10.1093/infdis/jiaa767.
4
Patient Characteristics and Costs Associated With COVID-19-Related Medical Care Among Medicare Fee-for-Service Beneficiaries.医疗保险按服务收费受益人与 COVID-19 相关医疗护理相关的患者特征和费用。
Ann Intern Med. 2021 Aug;174(8):1101-1109. doi: 10.7326/M21-1102. Epub 2021 Jun 1.
5
Predictors of COVID-19 severity and hospitalization: A survey-based study from Jordan.新冠病毒疾病严重程度及住院治疗的预测因素:一项来自约旦的基于调查的研究。
Inform Med Unlocked. 2022;31:100994. doi: 10.1016/j.imu.2022.100994. Epub 2022 Jun 14.
6
A cluster randomized controlled trial comparing relative effectiveness of two licensed influenza vaccines in US nursing homes: Design and rationale.一项在美国养老院中比较两种许可流感疫苗相对有效性的整群随机对照试验:设计与原理。
Clin Trials. 2016 Jun;13(3):264-74. doi: 10.1177/1740774515625976. Epub 2016 Feb 11.
7
Body Mass Index and Risk for COVID-19-Related Hospitalization, Intensive Care Unit Admission, Invasive Mechanical Ventilation, and Death - United States, March-December 2020.体重指数与 2020 年 3 月至 12 月期间 COVID-19 相关住院、重症监护病房收治、有创机械通气和死亡风险的关系-美国。
MMWR Morb Mortal Wkly Rep. 2021 Mar 12;70(10):355-361. doi: 10.15585/mmwr.mm7010e4.
8
Predicting Mortality Due to SARS-CoV-2: A Mechanistic Score Relating Obesity and Diabetes to COVID-19 Outcomes in Mexico.预测因 SARS-CoV-2 导致的死亡率:一个将肥胖和糖尿病与墨西哥 COVID-19 结局相关联的机制评分。
J Clin Endocrinol Metab. 2020 Aug 1;105(8). doi: 10.1210/clinem/dgaa346.
9
Clinical, demographical characteristics and hospitalisation of 3,010 patients with Covid-19 in Friuli Venezia Giulia Region (Northern Italy). A multivariate, population-based, statistical analysis.3010 例新冠病毒肺炎患者在弗留利-威尼斯朱利亚大区(意大利北部)的临床、人口统计学特征和住院情况。一项多变量、基于人群、统计学分析。
Epidemiol Prev. 2020 Sep-Dec;44(5-6 Suppl 2):226-234. doi: 10.19191/EP20.5-6.S2.122.
10
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.

引用本文的文献

1
Associations of Individual and Neighborhood Factors with Disparities in COVID-19 Incidence and Outcomes.个体因素和社区因素与新冠病毒疾病发病率及转归差异的关联
West J Emerg Med. 2025 Mar;26(2):315-325. doi: 10.5811/westjem.18526.
2
Risk Stratification Model for Severe COVID-19 Disease: A Retrospective Cohort Study.重症新型冠状病毒肺炎疾病风险分层模型:一项回顾性队列研究。
Biomedicines. 2023 Mar 2;11(3):767. doi: 10.3390/biomedicines11030767.
3
mRNA COVID-19 Vaccines-Facts and Hypotheses on Fragmentation and Encapsulation.mRNA新冠疫苗——关于片段化和封装的事实与假说

本文引用的文献

1
Racial and Ethnic Disparities in Rates of COVID-19-Associated Hospitalization, Intensive Care Unit Admission, and In-Hospital Death in the United States From March 2020 to February 2021.2020 年 3 月至 2021 年 2 月期间美国 COVID-19 相关住院率、重症监护病房入院率和住院死亡率的种族和民族差异。
JAMA Netw Open. 2021 Oct 1;4(10):e2130479. doi: 10.1001/jamanetworkopen.2021.30479.
2
Racial and ethnic differences in COVID-19 hospitalizations by metropolitan status among Medicare beneficiaries, 1 January-31 December 2020.2020 年 1 月 1 日至 12 月 31 日,医疗保险受益人群按大都市地位划分的 COVID-19 住院的种族和民族差异。
J Public Health (Oxf). 2022 Jun 27;44(2):e211-e220. doi: 10.1093/pubmed/fdab355.
3
Vaccines (Basel). 2022 Dec 24;11(1):40. doi: 10.3390/vaccines11010040.
4
Enhanced Vaccine Effectiveness during the Delta Phase of the COVID-19 Pandemic in the Medicare Population Supports a Multilayered Prevention Approach.新冠疫情德尔塔阶段医疗保险人群中增强的疫苗效力支持多层预防方法。
Biology (Basel). 2022 Nov 24;11(12):1700. doi: 10.3390/biology11121700.
5
A Calculator for COVID-19 Severity Prediction Based on Patient Risk Factors and Number of Vaccines Received.基于患者风险因素和接种疫苗数量的新冠肺炎严重程度预测计算器。
Microorganisms. 2022 Jun 16;10(6):1238. doi: 10.3390/microorganisms10061238.
6
"MATH+" Multi-Modal Hospital Treatment Protocol for COVID-19 Infection: Clinical and Scientific Rationale.“MATH+”新冠病毒感染多模式医院治疗方案:临床与科学依据
J Clin Med Res. 2022 Feb;14(2):53-79. doi: 10.14740/jocmr4658. Epub 2022 Feb 24.
7
Re: Karin Welén, Ebba Rosendal, Magnus Gisslén, et al. A Phase 2 Trial of the Effect of Antiandrogen Therapy on COVID-19 Outcome: No Evidence of Benefit, Supported by Epidemiology and In Vitro Data. Eur Urol. 2022;81:285-93: Positive Effects of Enzalutamide for Hospitalized COVID-19 Patients.回复:卡琳·韦伦、埃巴·罗森达尔、马格努斯·吉斯伦等人。抗雄激素疗法对COVID-19结局影响的2期试验:无获益证据,有流行病学和体外数据支持。《欧洲泌尿外科杂志》。2022年;81:285 - 93:恩杂鲁胺对住院COVID-19患者的积极作用
Eur Urol. 2022 Jun;81(6):e141-e142. doi: 10.1016/j.eururo.2022.01.049. Epub 2022 Feb 23.
8
Demographics, Socioeconomic Context, and the Spread of Infectious Disease: The Case of COVID-19.人口统计学、社会经济背景与传染病的传播:以 COVID-19 为例。
Int J Environ Res Public Health. 2022 Feb 15;19(4):2206. doi: 10.3390/ijerph19042206.
9
Predicting COVID-19 severity using major risk factors and received vaccines.利用主要风险因素和接种疫苗情况预测新冠病毒疾病的严重程度。
medRxiv. 2022 Jan 3:2021.12.31.21268575. doi: 10.1101/2021.12.31.21268575.
How to Leverage the Medicare Program for a COVID-19 Vaccination Campaign.
如何利用医疗保险计划开展新冠疫苗接种活动。
JAMA. 2021 Jan 5;325(1):21-22. doi: 10.1001/jama.2020.22720.
4
Distinct effects of asthma and COPD comorbidity on disease expression and outcome in patients with COVID-19.哮喘与慢性阻塞性肺疾病(COPD)共病对新型冠状病毒肺炎(COVID-19)患者疾病表现及预后的不同影响。
Allergy. 2021 Feb;76(2):483-496. doi: 10.1111/all.14517. Epub 2020 Aug 11.
5
Disparities In Outcomes Among COVID-19 Patients In A Large Health Care System In California.加利福尼亚州大型医疗保健系统中 COVID-19 患者的结局差异。
Health Aff (Millwood). 2020 Jul;39(7):1253-1262. doi: 10.1377/hlthaff.2020.00598. Epub 2020 May 21.
6
Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York.在纽约布朗克斯的 COVID-19 患者队列中,严重肥胖、年龄增长和男性性别与住院期间的不良结局独立相关,并与更高的住院死亡率相关。
Metabolism. 2020 Jul;108:154262. doi: 10.1016/j.metabol.2020.154262. Epub 2020 May 16.
7
Chronic obstructive pulmonary disease is associated with severe coronavirus disease 2019 (COVID-19).慢性阻塞性肺疾病与严重的2019冠状病毒病(COVID-19)相关。
Respir Med. 2020 Jun;167:105941. doi: 10.1016/j.rmed.2020.105941. Epub 2020 Mar 24.
8
COVID-19 in older people: a rapid clinical review.老年人 COVID-19:快速临床综述。
Age Ageing. 2020 Jul 1;49(4):501-515. doi: 10.1093/ageing/afaa093.
9
Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area.在纽约市地区,5700 名因 COVID-19 住院的患者的特征、合并症和结局。
JAMA. 2020 May 26;323(20):2052-2059. doi: 10.1001/jama.2020.6775.
10
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 - COVID-NET, 14 States, March 1-30, 2020.2020 年 3 月 1 日至 30 日,14 个州住院的经实验室确诊的 2019 冠状病毒病患者的住院率和特征 - COVID-NET。
MMWR Morb Mortal Wkly Rep. 2020 Apr 17;69(15):458-464. doi: 10.15585/mmwr.mm6915e3.